Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:00 pm Purchase | 2025-09-30 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,957,957 8.900% | 524,789 (+21.57%) | Filing History |
| 2024-11-14 3:36 pm Purchase | 2024-09-30 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,433,168 8.200% | 400 (+0.02%) | Filing History |
| 2024-10-02 4:30 pm Sale | 2024-10-01 | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I, L.P. | 24,758 2.560% | -28,211 (-53.26%) | Filing History |
| 2024-09-06 4:59 pm Sale | 2024-08-19 | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I, L.P. | 52,969 5.500% | -25,057 (-32.11%) | Filing History |
| 2024-04-16 09:15 am Sale | 2024-04-05 | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I, L.P. | 78,026 8.100% | -6,382 (-7.56%) | Filing History |
| 2024-02-02 09:20 am Purchase | 2023-12-31 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,432,768 9.300% | 63,765 (+2.69%) | Filing History |
| 2023-02-14 08:22 am Purchase | 2022-12-31 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,369,003 9.500% | 60,000 (+2.60%) | Filing History |
| 2023-01-09 5:00 pm Purchase | 2022-06-24 | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I, L.P. | 84,408 9.200% | 39,458 (+87.78%) | Filing History |
| 2022-02-10 5:02 pm Sale | 2021-12-31 | 13G | GALECTO INC GLTO | Soleus Private Equity Fund I, L.P. | 0 0.000% | -60,506 (Position Closed) | Filing History |
| 2022-02-10 5:00 pm Purchase | 2021-12-31 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 2,309,003 9.500% | 473,663 (+25.81%) | Filing History |
| 2021-11-01 5:16 pm Purchase | 2021-04-26 | 13G | NEUROPACE INC NPCE | Soleus Private Equity Fund I, L.P. | 1,835,340 7.600% | 1,835,340 (New Position) | Filing History |
| 2021-09-03 5:16 pm Sale | 2021-08-24 | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I, L.P. | 44,950 6.950% | -10,935 (-19.57%) | Filing History |
| 2021-06-28 4:32 pm Sale | 2021-06-17 | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I, L.P. | 55,885 8.690% | -8,000 (-12.52%) | Filing History |